Latest KFF Health News Stories
What the Health? From KFF Health News: Kennedy Cancels Vaccine Funding
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
Sorting Out Covid Vaccine Confusion: New and Conflicting Federal Policies Raise Questions
Should you get vaccinated? Will your insurer pay for it? And will you still be able to find a vaccine? KFF Health News tries to sort out where things stand.
Aclarando la confusión sobre las vacunas contra covid-19
Las agencias dentro del Departamento de Salud y Servicios Sociales responsables de especificar quién debe vacunarse no están necesariamente sincronizadas, emitiendo recomendaciones en apariencia contradictorias.
What the Health? From KFF Health News: Next on Kennedy’s List? Preventive Care and Vaccine Harm
Robert F. Kennedy Jr., the secretary of Health and Human Services, is eyeing an overhaul of two more key entities as part of his ongoing effort to reshape health policy. And President Donald Trump signed an executive order last week that would enable localities to force some homeless people into residential treatment. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews Sara Rosenbaum, one of the nation’s leading experts on Medicaid, to mark Medicaid’s 60th anniversary this week.
What the Health? From KFF Health News: Here Come the ACA Premium Hikes
Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
What the Health? From KFF Health News: The Senate Saves PEPFAR Funding — For Now
The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
What RFK Jr. Isn’t Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
A new drug is helping families who’ve spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress — and a broader understanding of obesity — is now under threat as the government dismantles the pipeline for promising new research.
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
At Trump’s FDA, Anti-Regulatory Approach and Cost-Cutting Put Food Safety System at Risk
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Silence on E. Coli Outbreak Highlights How Trump Team’s Changes Undermine Food Safety
Food safety inspections are being scaled back and the public was not notified after an investigation into E. coli contamination.
En lo que expertos califican como un cambio radical de las prácticas habituales, las autoridades nunca emitieron comunicados públicos luego de la investigación.
What the Health? From KFF Health News: Bill With Billions in Health Program Cuts Passes House
The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending. But the Senate is expected to make major changes to the measure before it can go to President Donald Trump for his signature. This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico.
Trump’s Team Cited Safety in Limiting Covid Shots. Patients, Health Advocates See More Risk.
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.
This News Might Ruin Your Appetite — And Summer
Fresh studies expose a gap in the FDA’s assessments of foods: Widely used additives could damage the mix of bacteria in your gut, causing health problems.
What the Health? From KFF Health News: GOP Tries To Cut Billions in Health Benefits
GOP-controlled House committees approved parts of President Donald Trump’s “one big, beautiful bill” this week, including more than $700 billion in cuts to health programs over the next decade — mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldn’t take medical advice from him. Julie Appleby of KFF Health News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
What the Health? From KFF Health News: Cutting Medicaid Is Hard — Even for the GOP
Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.
Sen. Ron Wyden Seeks Answers on RFK Jr.’s Purge of FOIA Staff
“Citizen oversight is a cornerstone of a functioning democracy,” Oregon Sen. Ron Wyden wrote to Health and Human Services Secretary Robert F. Kennedy Jr., demanding answers to more than two dozen questions, including who was involved in decisions to fire staff who handled Freedom of Information Act requests.
Watch: How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
To a great extent, the FDA leaves it to food companies to determine whether their ingredients and additives are safe. Some chemicals and additives are tied to health risks while others are absent from product labels. Watch this video explainer to learn more.
In Reversal, FDA Rehires Staff Tasked With Releasing Public Records
At least some workers who process public records in response to Freedom of Information Act requests have been reinstated, agency employees say.
